Neuropsychology of Generalized Anxiety Disorder in Clinical Setting: A Systematic Evaluation.
Evgenia GkintoniPaula Suárez OrtizPublished in: Healthcare (Basel, Switzerland) (2023)
This research paper provides a systematic review of the neuropsychology of generalized anxiety disorder (GAD), examining relevant articles' methodologies and subject matter and highlighting key findings. It suggests potential cognitive deficits in GAD patients, such as subtle attention, executive function, and working memory deficiencies. It also discusses neural correlates of GAD, particularly the hyperactivity in the amygdala and insula, and the additional impact of comorbidity with other psychiatric disorders. The paper uses the PRISMA methodology and draws data from the PsycINFO, Scopus, PubMed, and Elsevier databases. Although the reviewed research has contributed to understanding GAD's cognitive and neural mechanisms, further research is required. Additionally, the paper mentions the clinical neuropsychology of GAD, including strategies and treatments, such as cognitive behavioral therapy (CBT), mindfulness, and medication. Lastly, the review identifies the limitations of the existing research and recommends future directions to enhance the understanding of GAD's underlying cognitive and neural mechanisms. The neural underpinnings of GAD encompass heightened activity within the amygdala and insula, which are brain regions implicated in processing adverse emotional reactions. Co-occurring psychiatric disorders, such as major depressive disorder (MDD), can also impact neuropsychological functioning. Additional investigation is warranted to better understand the intricate interplay between GAD, cognitive performance, and underlying neural processes.
Keyphrases
- major depressive disorder
- working memory
- functional connectivity
- resting state
- bipolar disorder
- end stage renal disease
- chronic kidney disease
- healthcare
- randomized controlled trial
- newly diagnosed
- ejection fraction
- emergency department
- big data
- attention deficit hyperactivity disorder
- genome wide
- blood brain barrier
- prognostic factors
- adverse drug
- artificial intelligence
- systematic review
- prefrontal cortex
- cerebral ischemia
- current status
- meta analyses